Overview | Medtronic
Medtronic Investors

Creating
Long-term
Shareholder
Value

Our leading technologies and services create value on a global scale.

Learn More

Latest Investor Information

June 08, 2017
Medtronic plc at the Jefferies 2017 Global Healthcare Conference
June 10, 2017
Medtronic plc Analyst Briefing at the American Diabetes Association (ADA) 2017 Annual Meeting
June 13, 2017
Medtronic plc at the Goldman Sachs 38th Annual Global Healthcare Conference

Latest Press Releases

June 28, 2017Medtronic SureTune(TM)3 Earns CE Mark for Deep Brain Stimulation Therapy
June 26, 2017Medtronic Announces Outcomes-Based Agreement with Aetna for Type 1 and Type 2 Diabetes Patients
June 23, 2017Medtronic Announces 7 Percent Increase in Cash Dividend
June 20, 2017New Data Reveal Medtronic CRT Devices Improve Therapy Delivery and Reduce Healthcare Costs
Read More

Medtronic Dividend

Tax Treatment

Medtronic Dividend U.S. Tax Treatment & Return of Capital
(ROC) Basis Adjustments

LEARN MORE

Opportunities to Obtain Irish Dividend Withholding Tax (DWT) Exemption

Important Information on the Irish Dividend Withholding Tax.

LEARN MORE

QUARTERLY

RESULTS

Medtronic Q3 revenue results and financial tables.

LEARN MORE

INVESTOR

FUNDAMENTALS

View snapshots of revenue and earnings, trading statistics, balance sheet, income statement, cash flow and ratios.

LEARN MORE
img.alt

Sustainability Index Endorsements

Read more about our Sustainability efforts.

READ MORE
 
img.alt

Medtronic Spotlight

CNBC’s Meg Tirrell talks to Medtronic CEO Omar Ishrak at the Piper Jaffray Healthcare Heartland Summit about growth, pricing and other challenges facing the industry.

Play Video
 
img.alt

Focus on Patients

The personal connection between Medtronic plc, its employees and patients.

Play Video
 
img.alt

History of Medtronic

A video history of the company.

Play Video

Investor Contacts

Stock Transfer Agent

Wells Fargo Shareowner Services
+1 888-648-8154

Medtronic Investor Relations Department

investor.relations@medtronic.com

+1 763-505-2692

Ryan Weispfenning

Vice President, Investor Relations

View All
X